(DPW) (FDO) (LOCO) Higher; (ACRX) (HZNP) (EDAP) Lower

July 28, 2014 4:59 PM

4 0

Horizon Pharma (Nasdaq: HZNP) 33.9% LOWER; said it was verbally notified that in August 2014, two pharmacy benefit managers (“PBMs”), CVS Caremark and Express Scripts, Inc., expect to announce DUEXIS and VIMOVO will no longer be on their formularies and will be placed on their exclusion lists effective January 1, 2015.

EDAP TMS SA (Nasdaq: EDAP) 27.3% LOWER; announced that the U.S. Food and Drug Administration (FDA) concluded its routine inspection of EDAP's manufacturing site with no findings nor issuance of Form 483 observations.

Also read: Conwert recommends accepting Vonovia takeover offer in cash

Read more

To category page

Loading...